Why the study?
Allergic response to clopidogrel is a significant and difficult clinical problem after coronary stenting to prevent thrombosis, warranting discussion of alternative drugs.
Can prasugrel be used as an alternative antiplatelet agent in a patient with clopidogrel hypersensitivity?
Can prasugrel be used as an alternative antiplatelet agent in a patient with clopidogrel hypersensitivity?
Prasugrel may serve as a safe and effective alternative antiplatelet agent in patients who develop hypersensitivity to clopidogrel after coronary stenting.
Answers are grounded in this paper and cite their sources.
May support prasugrel as alternative after clopidogrel hypersensitivity; leaves open prospective validation.
Allergic response to clopidogrel is a significant and difficult clinical problem as it is one of the recommended drugs after coronary stenting to prevent thrombosis. We present the case of a 57-year-old man who underwent coronary revascularization and developed an urticarial rash after being started on dual antiplatelet medication (aspirin and clopidogrel). He was managed conservatively, to which he responded well and was discharged on prasugrel. This case study from India adds to the available literature and discusses the alternative drugs that could be used in patients with clopidogrel hypersensitivity.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: